Pasar al contenido principal

RIBONUCLEASAS E INTEINAS COMO HERRAMIENTAS MOLECULARES PARA EL DESARROLLO DE FARMACOS ANTITUMORALES Y ESTUDIO DE PROTEINOPATIAS

BIO2013-43517-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2013
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario UNIVERSITAT DE GIRONA
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural insights into subunits assembly and the oxyester splicing mechanism of neq pol split intein

  • Gordo, Verónica
  • Aparicio, David
  • Pérez-Luque, Rosa
  • Benito, Antoni
  • Vilanova, Maria
  • Usón, Isabel
  • Fita, Ignacio
  • Ribó, Marc
Split inteins are expressed as two separated subunits (N-intein and C-intein) fused to the corresponding exteins. The specific association of both intein subunits precedes protein splicing, which results in excision of the intein subunits and in ligation, by a peptide bond, of the concomitant exteins. Catalytically active intein precursors are typically too reactive for crystallization or even isolation. Neq pol is the trans-intein of the B-type DNA polymerase I split gene from hyperthermophile Nanoarchaeum equitans. We have determined the crystal structures of both the isolated NeqN and the complex of NeqN and NeqC subunits carrying the wild-type sequences, including the essential catalytic residues Ser1 and Thr+1, in addition to seven and three residues of the N- and C-exteins, respectively. These structures provide detailed information on the unique oxyester chemistry of the splicing mechanism of Neq pol and of the extensive rearrangements that occur in NeqN during the association step., This work has been supported by grants BIO2013-43517, BFU2015-71092-P and UNGI 10-4E-417 from MINECO (Spain) and SING12/0 from UdG. V.G. acknowledges her fellowship from the Universitat de Girona., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The Selectivity for Tumor Cells of Nuclear-Directed Cytotoxic RNases Is Mediated by the Nuclear/Cytoplasmic Distribution of p27KIP1

  • García Galindo, Glòria
  • Castro Gallegos, Jessica
  • Matés Ramírez, Jesús
  • Bravo Bonilla, Marlon Rolando
  • Ribó i Panosa, Marc
  • Vilanova i Brugués, Maria
  • Benito i Mundet, Antoni
Although single targeted anti-cancer drugs are envisaged as safer treatments because they do not affect normal cells, cancer is a very complex disease to be eradicated with a single targeted drug. Alternatively, multi-targeted drugs may be more effective and the tumor cells may be less prone to develop drug resistance although these drugs may be less specific for cancer cells. We have previously developed a new strategy to endow human pancreatic ribonuclease with antitumor action by introducing in its sequence a non-classical nuclear localization signal. These engineered proteins cleave multiple species of nuclear RNA promoting apoptosis of tumor cells. Interestingly, these enzymes, on ovarian cancer cells, affect the expression of multiple genes implicated in metabolic and signaling pathways that are critic for the development of cancer. Since most of these targeted pathways are not highly relevant for non-proliferating cells, we envisioned the possibility that nuclear directed-ribonucleases were specific for tumor cells. Here, we show that these enzymes are much more cytotoxic for tumor cells in vitro. Although the mechanism of selectivity of NLSPE5 is not fully understood, herein we show that p27KIP1 displays an important role on the higher resistance of non-tumor cells to these ribonucleases, This research was funded by MINECO (Spain), grant number BIO2013-43517 and by Universitat de Girona (Spain), grant number MPCU2016/18
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells

  • Vert Company, Anna
  • Castro Gallegos, Jessica
  • Ribó i Panosa, Marc
  • Benito i Mundet, Antoni
  • Vilanova i Brugués, Maria
Ribonucleases represent a new class of antitumor RNA-damaging drugs. However, many wild-type members of the vertebrate secreted ribonuclease family are not cytotoxic because they are not able to evade the cytosolic ribonuclease inhibitor. We previously engineered the human pancreatic ribonuclease to direct it to the cell nucleus where the inhibitor is not present. The best characterized variant is PE5 that kills cancer cells through apoptosis mediated by the p21WAF1/CIP1 induction and the inactivation of JNK. Here, we have used microarray-derived transcriptional profiling to identify PE5 regulated genes on the NCI/ADR-RES ovarian cancer cell line. RT-qPCR analyses have confirmed the expression microarray findings. The results show that PE5 cause pleiotropic effects. Among them, it is remarkable the down-regulation of multiple genes that code for enzymes involved in deregulated metabolic pathways in cancer cells, This work has been supported by grants BFU2009-06935 and BIO2013-43517 from MINECO (Spain) and SING12/0 from UdG (Spain).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A family of manganese complexes containing heterocyclic-based ligands with cytotoxic properties

  • Castro Gallegos, Jessica
  • Manrique Salas, Ester
  • Bravo Bonilla, Marlon Rolando
  • Vilanova i Brugués, Maria
  • Benito i Mundet, Antoni
  • Fontrodona, Xavier
  • Rodríguez Pizarro, Montserrat
  • Romero García, Isabel
We describe the synthesis of three new manganese (II) complexes containing the bidentate ligands 2-(1-methyl-3-pyrazolyl)pyridine (pypz-Me) and ethyl 2-(3-(pyridine-2-yl)-1H–pyrazol-1-yl)acetate (pypz-CH2COOEt), with formula [MnX2(pypz-Me)2] (X = Cl−1, CF3SO3−2) and [Mn(CF3SO3)2(pypz-CH2COOEt)2] 3. Complexes 1–3 have been characterized through analytical, spectroscopic and electrochemical techniques, as well as by monocrystal X-ray diffraction analysis. The complexes show a six-coordinated Mn(II) ion though different stereoisomers have been isolated for the three compounds. Complexes 1–3, together with the previously described compounds [MnCl2(pypz-H)2] 4, [Mn(CF3SO3)2(pypz-H)2] 5, [Mn(NO3)2(pypz-H)2] 6, [MnCl2(H2O)2(pypz-H)2] 7 (pypz-H = 2-(3-pyrazolyl)pyridine) and ([Mn(CF3SO3)2((−)-L)2] 8, ((−)-L = (−)-pinene[5,6]bipyridine), were tested in vitro for cytotoxic activity against NCI-H460 and OVCAR-8 cancer cell lines. The geometry of a specific compound does not seem to influence its activity in a significant extent. However, among the tested compounds those that display hydrophobic substituents on the pyrazole ring and triflate ions as labile ligands show the best antiproliferative properties. Specifically, compound 8 containing the pinene-bipyridine ligand presents an antiproliferative activity similar to that of cisplatin and higher than that of carboplatin, and displays selectivity for tumour cells. Its antiproliferative effect is due to the generation of ROS species that allow the compound to interact with DNA, This research has been financed by Ministerio de Economia y Competitividad (MINECO) Spain, through projects CTQ2015-66143-P and BIO2013-43517, by Universitat de Girona through projects MPCUdG2016-18 and MPCUdG2016/048 and by DGU, Generalitat de Catalunya through projects SGR2014-70 and SGR2014-149
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Dinuclear Iron Complexes of Iminopyridine-Based Ligands as Selective Cytotoxins for Tumor Cells and Inhibitors of Cancer Cell Migration

  • Castro Gallegos, Jessica
  • Bravo Bonilla, Marlon Rolando
  • Albertí, Meritxell
  • Marsal, Anaís
  • Alonso-De Gennaro, María José
  • Martínez-Ferraté, Oriol
  • Claver, Carmen
  • Leeuwen, Piet W. N. M. van
  • García, Isabel
  • Benito i Mundet, Antoni
  • Vilanova i Brugués, Maria
A family of dinuclear iron (II) compounds with iminopyridine-based ligands displays selective cytotoxic activity against cancer cell lines. All compounds have IC50 values 2–6 fold lower than that of cisplatin, and 30–90 fold lower than that of carboplatin for the tumor cell lines assayed. Comparing the IC50 values between tumor and non-tumor cell lines, the selectivity indexes range from 3.2 to 34, compound 10, [Fe2(4)2(CH3CN)4](BF4)4, showing the highest selectivity. Those compounds carrying substituents on the iminopyridine ring show the same cytotoxicity as those without substituents. However, the electronic effects of the substituents on position 6 may be important for the cytotoxicity of the complexes, and consequently for their selectivity. All compounds act over DNA, promoting cuts on both strands in the presence of reactive oxygen species. Since compound 10 presented the highest selectivity, its cytotoxic effect was further characterized. It induces apoptosis, affects cell cycle phase distribution in a cell-dependent manner, and its cytotoxic effect is linked to reactive oxygen species generation. In addition, it decreases tumor cell migration, showing potential antimetastatic effects. These properties make compound 10 a good lead antitumor agent among all compounds studied here, This research was financed by Ministerio de Economia y Competitividad (MINECO) Spain, through project BIO2013-43517, by Universitat de Girona through projects MPCUdG2016-18 and MPCUdG2016/048, and by DGU, Generalitat de Catalunya through projects SGR2014-70 and 2017 SGR 1720
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A Nuclear-Directed Ribonuclease Variant Targets Cancer Stem Cells and Inhibits Migration and Invasion of Breast Cancer Cells

  • Castro Gallegos, Jessica
  • Tornillo, Giusy
  • Ceada, Gerardo
  • Ramos-Neble, Beatriz
  • Bravo Bonilla, Marlon Rolando
  • Ribó i Panosa, Marc
  • Vilanova i Brugués, Maria
  • Smalley, Matthew J.
  • Benito i Mundet, Antoni
Despite the significant advances in cancer research made in recent years, this disease remains one of the leading causes of death worldwide. In part, this is due to the fact that after therapy, a subpopulation of self-renewing tumor cells can survive and promote cancer relapse, resistance to therapies and metastasis. Targeting these cancer stem cells (CSCs) is therefore essential to improve the clinical outcome of cancer patients. In this sense, multi-targeted drugs may be promising agents targeting CSC-associated multifocal effects. We have previously constructed different human pancreatic ribonuclease (RNase) variants that are cytotoxic for tumor cells due to a non-classical nuclear localization signal introduced in their sequence. These cytotoxic RNases affect the expression of multiple genes involved in deregulated metabolic and signaling pathways in cancer cells and are highly cytotoxic for multidrug-resistant tumor cell lines. Here, we show that these cytotoxic nuclear-directed RNases are highly selective for tumor cell lines grown in 3D, inhibit CSCs’ development and diminish the self-renewal capacity of the CSCs population. Moreover, these human RNase variants reduce the migration and invasiveness of highly invasive breast cancer cells and downregulate N-cadherin expression, M.J.S. and G.T. are funded by Breast Cancer Now, grant number 2018NovPR1211, and Breast Cancer Research Aid. This research was funded by minECO (Spain), grant number BIO2013-43517, and by Universitat de Girona (Spain), grant number MPCU2016/18
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Structural investigation of ribonuclease A conformational preferences using high pressure protein crystallography

  • Kurpiewska, Katarzyna
  • Dziubek, Kamil
  • Katrusiak, Andrzej
  • Font i Sadurní, Josep
  • Ribó i Panosa, Marc
  • Vilanova i Brugués, Maria
  • Lewiński, Krzysztof
Hydrostatic pressure in range 0.1-1.5 GPa is used to modify biological system behaviour mostly in biophysical studies of proteins in solution. Due to specific influence on the system equilibrium high pressure can act as a filter that enables to identify and investigate higher energy protein conformers. The idea of the presented experiments is to examine the behaviour of RNase A molecule under high pressure before and after introduction of destabilizing mutation. For the first time crystal structures of wild-type bovine pancreatic ribonuclease A and its markedly less stable variant modified at position Ile106 were determined at different pressures. X-ray diffraction experiments at high pressure showed that the secondary structure of RNase A is well preserved even beyond 0.67 GPa at room temperature. Detailed structural analysis of ribonuclease A conformation observed under high pressure revealed that pressure influences hydrogen bonds pattern, cavity size and packing of molecule, This work has been supported by Grants BFU2009-06935 and BIO2013-43517 from MINECO (Spain)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Construction of Highly Stable Cytotoxic Nuclear-Directed Ribonucleases

  • Roura Padrosa, David
  • Castro Gallegos, Jessica
  • Romero Casañas, Alejandro
  • Ribó i Panosa, Marc
  • Vilanova i Brugués, Maria
  • Benito i Mundet, Antoni
Ribonucleases are proteins whose use is promising in anticancer therapy. We have previously constructed different human pancreatic ribonuclease variants that are selectively cytotoxic for tumor cells by introducing a nuclear localization signal into their sequence. However, these modifications produced an important decrease in their stability compromising their behavior in vivo. Here, we show that we can significantly increase the thermal stability of these cytotoxic proteins by introducing additional disulfide bonds by site-directed mutagenesis. One of these variants increases its thermal stability by around 17 °C, without affecting its catalytic activity while maintaining the cytotoxic activity against tumor cells. We also show that the most stable variant is significantly more resistant to proteolysis when incubated with proteinase K or with human sera, suggesting that its half-live could be increased in vivo once administered, This research was funded by MINECO (Spain), grant number BIO2013-43517 and by Universitat de Girona (Spain), grant number MPCU2016/18
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Ligation of multiple protein domains using orthogonal inteins with non-native splice junctions

  • Romero Casañas, Alejandro
  • García-Lizarribar, Andrea
  • Castro Gallegos, Jessica
  • Vilanova i Brugués, Maria
  • Benito i Mundet, Antoni
  • Ribó i Panosa, Marc
Protein splicing is a self-catalyzed process in which an internal protein domain (the intein) is excised from its flanking sequences, linking them together with a canonical peptide bond. Trans-inteins are separated in two different precursor polypeptide chains that must assemble to catalytically self-excise and ligate the corresponding flanking exteins to join even when expressed separately either in vitro or in vivo. They are very interesting to construct full proteins from separate domains because their common small size favors chemical synthesis approaches. Therefore, trans-inteins have multiple applications such as protein modification and purification, structural characterization of protein domains or production of intein-based biosensors, among others. For many of these applications, when using more than one trans-intein, orthogonality between them is a critical issue to ensure the proper ligation of the exteins. Here, we confirm the orthogonality (lack of cross-reactivity) of four different trans- or split inteins, gp41-1, gp41-8, IMPDH-1 and NrdJ-1 both in vivo and in vitro, and built different constructs that allow for the sequential fusion of up to four protein fragments into one final spliced product. We have characterized the splicing efficiency of these constructs. All harbor non-native extein residues at the splice junction between the trans-intein and the neighboring exteins, except for the essential Ser + 1. Our results show that it is possible to ligate four different protein domains using inteins gp41-1, IMPDH-1 and NrdJ-1 with non-native extein residues to obtain a final four-domain spliced product with a not negligible yield that keeps its native sequence, This research was financed by Ministerio de Economia y Competitividad, through project BIO2013-43517, by Universitat de Girona through projects MPCUdG2016-18, and by DGU, Generalitat de Catalunya through project 2017-SGR 1720, Open Access funding provided thanks to the CRUE-CSIC agreement with Wiley